Results 71 to 80 of about 2,426 (130)

[Effect and mechanism of astaxanthin on the aging of high glucose-treated human skin fibroblasts]. [PDF]

Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi
Tang LJ, Fan LH, Wang JR, Luo M, Yang XX, Zhong RQ, Gao HY.   +6 more
europepmc   +1 more source

[β-sitosterol, an important component in the fruits of <i>Alpinia oxyphylla</i> Miq., prolongs lifespan of <i>Caenorhabditis elegans</i> by suppressing the ferroptosis pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Li J, Chen S, Xie L, Wang J, Cheng A, Zhang S, Lin J, Fang Z, Pan Y, Cui C, Chen G, Zhang C, Li L.   +12 more
europepmc   +1 more source

[Progress in metabolomics of multiple myeloma]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Ye X, Sun ZX, Qu XY, Fan L.
europepmc   +1 more source

[Extracellular matrix materials and tissue regeneration and repair]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Zhao L, Xie H.
europepmc   +1 more source

[Gastrodin inhibits ferroptosis to alleviate hypoxic-ischemic brain damage in neonatal mice by activating GPX4/SLC7A11/FTH1 signaling]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Guo T, Chen B, Shi J, Kuang X, Yu T, Wei S, Liu X, Xiao R, Li J.   +8 more
europepmc   +1 more source

PI3K抑制剂XC302连续给药治疗晚期实体肿瘤的I期临床耐受性试验

Zhongshan Daxue xuebao. Yixue kexue ban, 2015
摘 要: 【目的】 确定PI3K抑制剂XC302连续口服给药的剂量限制性毒性(DLT)和最大耐受剂量(MTD),评估其耐受性并初步观察XC302治疗晚期实体肿瘤患者的疗效?【方法】常规治疗失败的晚期实体肿瘤患者分别进入4个组别接受XC302 每天1次或每天2次口服治疗,起始剂量为50 mg/d,按“3+3”模式进行剂量递增或根据前一阶段试验结果调整?根据NCI-CTCAE 3.0版毒性评定标准评估不良反应?按RECIST 1.0版标准进疗效评估?【结果】共入组30例晚期肿瘤患者 ...
doaj  

[Application and advances of exosome-hydrogel system in wound healing]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Qiu Y, Tan Q.
europepmc   +1 more source

[Research Advances on the Autophagy and Ferroptosis 
in the Development and Treatment of Lung Cancer]. [PDF]

Zhongguo Fei Ai Za Zhi
Jiang C, Cui X, Zheng L, Deng C, Huang R, Hou B, Wang J.   +6 more
europepmc   +1 more source

Research progress on bioactive peptides in the treatment of oral diseases. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Huang W, Wang Y, Wang X, Li K.
europepmc   +1 more source

[Advances in hydrogel drug delivery systems for myocardial infarction treatment]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Yang J, Zhou Z, Xie X, Ye M.
europepmc   +1 more source